Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_assertion type Assertion NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_head.
- NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_assertion description "[These data suggest that p16 deletion adversely impacts the outcomes of BRAF-driven gliomas, that high proliferation index may be a better marker of progression risk than BRAF, that BRAF rearrangement and BRAF V600E might not necessarily produce comparable outcomes, and that none of these markers is stronger than tumor location in determining prognosis in pediatric low-grade gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_provenance.
- NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_assertion evidence source_evidence_literature NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_provenance.
- NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_assertion SIO_000772 22492957 NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_provenance.
- NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_assertion wasDerivedFrom befree-2016 NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_provenance.
- NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_assertion wasGeneratedBy ECO_0000203 NP973900.RAj7W8Iiy4Mh0PCuQeZ7HcPTdj8Z9VmKVtfU8SJr8TmMQ130_provenance.